Literature DB >> 6777303

Slime glycolipoproteins and the pathogenicity of various strains of Pseudomonas aeruginosa in experimental infection.

G Dimitracopoulos, P F Bartell.   

Abstract

Several strains of Pseudomonas aeruginosa were differentiated on the basis of the surface properties of the cells. Fisher immunotype, phage type, polysaccharide depolymerase type, and indirect hemagglutination reactions were used for this purpose. Each strain was then studied with respect to events known to occur during the experimental infection of mice with P. aeruginosa. The virulence of the viable cells varied significantly, although all strains were virulent. Glycolipoproteins were isolated from the slime of each strain, and they appeared similar chemically when they were analyzed for gross composition. The toxicity of the isolated glycolipoproteins varied insignificantly, except for that of one strain. Viable cells of each strain and their respective glycolipoproteins caused leukopenia, which occurs in the course of the lethal infection. The antisera to the glycolipoproteins protected mice in every case against infection by the homologous strains. In some cases, various degrees of cross-protection were observed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6777303      PMCID: PMC551326          DOI: 10.1128/iai.30.2.402-408.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis.

Authors:  P V LIU; Y ABE; J L BATES
Journal:  J Infect Dis       Date:  1961 Mar-Apr       Impact factor: 5.226

2.  Purification and properties of polysaccharide depolymerase associated with phage-infected Pseudomonas aeruginosa.

Authors:  P F Bartell; G K Lam; T E Orr
Journal:  J Biol Chem       Date:  1968-05-10       Impact factor: 5.157

3.  New immunotype schema for Pseudomonas aeruginosa based on protective antigens.

Authors:  M W Fisher; H B Devlin; F J Gnabasik
Journal:  J Bacteriol       Date:  1969-05       Impact factor: 3.490

4.  The slime of Pseudomonas aeruginosa: biological characterization and possible role in experimental infection.

Authors:  J W Sensakovic; P F Bartell
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

5.  Biological activity of fragments derived from the extracellular slime glycolipoprotein of Pseudomonas aeruginosa.

Authors:  J W Sensakovic; P F Bartell
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

6.  Phage-related surface modifications of Pseudomonas aeruginosa: effects on the biological activity of viable cells.

Authors:  G Dimitracopoulos; P F Bartell
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

7.  Isolation and characterization of a high-molecular-weight polysaccharide from the slime of Pseudomonas aeruginosa.

Authors:  G B Pier; H F Sidberry; S Zolyomi; J C Sadoff
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

8.  Polysaccharide depolymerase associated with bacteriophage infection.

Authors:  P F Bartell; T E Orr; G K Lam
Journal:  J Bacteriol       Date:  1966-07       Impact factor: 3.490

9.  Distinct slime polysaccharide depolymerases of bacteriophage-infected Pseudomonas aeruginosa: evidence of close association with the structured bacteriophage particle.

Authors:  P F Bartell; T E Orr
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

10.  Slime of Pseudomonas aeruginosa: in vivo production.

Authors:  G Dimitracopoulos; J W Sensakovic; P F Bartell
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

View more
  8 in total

1.  Immunochemical and biochemical analysis of the polyvalent Pseudomonas aeruginosa vaccine PEV.

Authors:  S MacIntyre; T McVeigh; P Owen
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

2.  Smooth lipopolysaccharide is the major protective antigen for mice in the surface extract from IATS serotype 6 contributing to the polyvalent Pseudomonas aeruginosa vaccine PEV.

Authors:  S MacIntyre; R Lucken; P Owen
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

3.  Phagocytosis and killing of Pseudomonas aeruginosa by mouse polymorphonuclear leukocytes in vitro promoted by antiserum to the slime glycolipoprotein.

Authors:  O Bishop; T Orr; P F Bartell
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

4.  Biochemical alterations in the mouse induced by Pseudomonas aeruginosa and its slime glycolipoprotein.

Authors:  M Lynn; L Lotz
Journal:  Br J Exp Pathol       Date:  1984-04

5.  Pseudomonas aeruginosa slime glycolipoprotein is a potent stimulant of tumor necrosis factor alpha gene expression and activation of transcription activators nuclear factor kappa B and activator protein 1 in human monocytes.

Authors:  George Lagoumintzis; Myrto Christofidou; George Dimitracopoulos; Fotini Paliogianni
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

6.  Polysaccharide of the slime glycolipoprotein of Pseudomonas aeruginosa.

Authors:  L H Koepp; T Orr; P F Bartell
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

7.  Comparative evaluation of mitogenicity and basement-membrane-degrading activity of Pseudomonas aeruginosa slime glycolipoprotein and alginate.

Authors:  E D Anastassiou; G Karakiulakis; E Missirlis; M E Maragoudakis; G Dimitracopoulos
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

8.  Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with exotoxin A toxoids.

Authors:  O R Pavlovskis; D C Edman; S H Leppla; B Wretlind; L R Lewis; K E Martin
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.609

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.